Welcome
Support Centre
12 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Acupuncture for Sequelae of Bell's Palsy
ISRCTN ISRCTN43104115
ClinicalTrials.gov identifier
Public title Acupuncture for Sequelae of Bell's Palsy
Scientific title Acupuncture for Sequelae of Bell's Palsy: a randomised wait-list controlled pilot trial
Acronym N/A
Serial number at source komc mirb 2010 - 01
Study hypothesis The primary objective of the present protocol is to investigate the effectiveness of acupuncture in patients with sequelae of Bell's palsy, compared to a no-acupuncture waitlist status.
Lay summary Not provided at time of registration
Ethics approval Kyung-Hee University Medical Center Ethics Committee approved on the 11th of June 2010
Study design Randomised assessor blind wait list controlled pilot trial
Countries of recruitment Korea, South
Disease/condition/study domain Sequelae of Bell's palsy
Participants - inclusion criteria 1. Aged between 18-65
2. Diagnosis of Bell's palsy (ICD-10 G51.0), at least 6 months prior to recruitment
3. FDI (Facial Disability Index) score of below 70 in Physical Function, and below 80 in Social/Well-being Function
4. Provided written informed consent
Participants - exclusion criteria 1. Secondary facial palsy resulting from specific disease such as infection, multiple neuritis, tumour invading the temporal region, cerebral contusion or stroke
2. Patient manifesting Ramsay-Hunt syndrome
3. Bilateral facial palsy
4. Recurred facial palsy
5. Received orally administered corticosteroids or anti-viral agent(aciclovir, valaciclovir, famciclovir, ganciclovir) within 1 month before enrolment
6. Received alternative and complementary modality, i.e. acupuncture, moxibustion, vesicant therapy or massage for treating Bell's palsy within 3 months
7. Received operation, i.e. facial nerve decompression, facial nerve and muscle reconstruction for treating Bell's palsy
8. Suffering serious medical condition such as uncontrolled hypertension, diabetes mellitus requiring insulin injection, past or current malignant tumour, severe dyslipidemia or liver and kidney dysfunction, anaemia, active pulmonary tuberculosis, other infectious disease or systemic diseases insufficient for acupuncture treatment
9. Other neurologic illness
10. Participating in another clinical trial
11. Suffering psychiatric illness insufficient for participation in clinical trial
12. Unable to obtain written consent
13. Pregnant or nursing status, or planning conception during treatment
14. Scar in administration area or systemic illness unsuitable for acupuncture treatment in the judgement of the investigator
Anticipated start date 01/08/2010
Anticipated end date 30/04/2011
Status of trial Completed
Patient information material Not available in web format, please use contact details to request a patient information sheet
Target number of participants 20 participants in experiment group (acupuncture treatment), 10 participants in control group (wait list)
Interventions The study includes the following periods in all groups: a treatment period of 8 weeks (3 sessions/week), and a follow-up period of 4 weeks.

Acupuncture group:
In the acupuncture treatment group, 18 acupuncture points (ipsilateral ST4, ST6 on the unaffected side, ipsilateral ST1, EX-HN4, TE23, LI20 on the affected side, and bilateral TE17, ST9, LI10, LI4, ST36, GB34) will be inserted with 0.20 mm in diameter x 30 mm in length disposal needles. The needle will be inserted to a depth of 5 - 10 mm, according to the points selected. The participating acupuncture doctors will manually manipulate the acupuncture needles with de-qi sensation and maintain the needles for 10 minutes.

Waitlist:
Participants who will be allocated to waitlist will receive no acupuncture treatment throughout the 8 weeks. After 8 weeks, if participants elect to try the acupuncture treatment it will be provided, acupuncture treatment period of 8 weeks (3 sessions/week).
Primary outcome measure(s) Changes in FDI (Facial Disability Index) after 24 sessions/8 weeks of acupuncture treatment.
Secondary outcome measure(s) Changes in the following, after 24 sessions/8 weeks of acupuncture treatment and one-month follow-up:
1. Sunnybrook Facial Grading System
2. H-B Scale
3. Lip-length and snout indices
4. Facial stiffness
Sources of funding Kyung Hee University (South Korea) - Research Fund in 2010 (KHU-20100699)
Trial website
Publications 1. 2011 protocol in http://www.ncbi.nlm.nih.gov/pubmed/21388554
Contact name Prof  Jong-In  Kim
  Address Dongdaemun-gu
Hoegi-dong #1
Kyung Hee Medical Center
  City/town Seoul
  Zip/Postcode 130-702
  Country Korea, South
  Email hann8400@hanmail.net
Sponsor Kyung Hee University (South Korea)
  Address Dongdaemun-gu
Hoegi-dong #1
  City/town Seoul
  Zip/Postcode 130-701
  Country Korea, South
  Email khsa0051@khu.ac.kr
Date applied 25/06/2010
Last edited 11/07/2011
Date ISRCTN assigned 06/07/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central